The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis - PubMed (original) (raw)
Affiliations
- PMID: 7739505
Review
The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis
T Owens et al. Neurol Clin. 1995 Feb.
Abstract
Two questions were posed at the beginning of this article. Is EAE a good model for MS? And, is MS an autoimmune disease? The first question is easier to address than the second. EAE is the best available model for the inflammatory processes that occur in MS, and for the disease process. The latter depends somewhat on study of chronic relapsing EAE, rather than early or mono-episodic EAE, which, although of great immunological interest, is of less relevance to the established disease that presents as MS. The second question asks whether MS fulfills Koch's postulates as an autoimmune disease. MS has all the hallmarks of an inflammatory disease of the CNS. The question then is whether the inflammation is autoimmune. The evidence presented shows a considerable autoimmune component to MS inflammation, raising the subsidiary question of whether autoimmune reactivity induces MS. This remains unanswerable for the present, and it should be kept in mind that the same question also would be unanswerable by observation of EAE. The major postulate therefore remains unfulfilled. Diagnosis of MS as an autoimmune disease requires definitive identification of the autoantigen; otherwise, the possibility remains open that this is a disease resulting from the inadvertent activation and dysregulation of immune processes in the CNS that, themselves, are not directed at that organ.
Similar articles
- Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis.
Martin R, McFarland HF. Martin R, et al. Crit Rev Clin Lab Sci. 1995;32(2):121-82. doi: 10.3109/10408369509084683. Crit Rev Clin Lab Sci. 1995. PMID: 7598789 Review. - Experimental allergic encephalomyelitis animal models for analyzing features of multiple sclerosis.
Petry KG, Boullerne AI, Pousset F, Brochet B, Caillé JM, Dousset V. Petry KG, et al. Pathol Biol (Paris). 2000 Feb;48(1):47-53. Pathol Biol (Paris). 2000. PMID: 10729911 Review. - New insights into cell responses involved in experimental autoimmune encephalomyelitis and multiple sclerosis.
El Behi M, Dubucquoi S, Lefranc D, Zéphir H, De Seze J, Vermersch P, Prin L. El Behi M, et al. Immunol Lett. 2005 Jan 15;96(1):11-26. doi: 10.1016/j.imlet.2004.07.017. Immunol Lett. 2005. PMID: 15585303 Review. - [Multiple sclerosis and experimental autoimmune encephalomyelitis].
Béraud-Juven E. Béraud-Juven E. Rev Prat. 1994 Jan 1;44(1):69-74. Rev Prat. 1994. PMID: 8178062 French. - Intravenous immunoglobulin treatment of multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.
Humle Jorgensen S, Sorensen PS. Humle Jorgensen S, et al. J Neurol Sci. 2005 Jun 15;233(1-2):61-5. doi: 10.1016/j.jns.2005.03.005. Epub 2005 Apr 22. J Neurol Sci. 2005. PMID: 15949496 Review.
Cited by
- Differential influence of interleukin-12 in the pathogenesis of autoimmune and virus-induced central nervous system demyelination.
Bright JJ, Rodriguez M, Sriram S. Bright JJ, et al. J Virol. 1999 Feb;73(2):1637-9. doi: 10.1128/JVI.73.2.1637-1639.1999. J Virol. 1999. PMID: 9882371 Free PMC article. - The Role of Mesenchymal Stem Cells in Modulating Adaptive Immune Responses in Multiple Sclerosis.
Dadfar S, Yazdanpanah E, Pazoki A, Nemati MH, Eslami M, Haghmorad D, Oksenych V. Dadfar S, et al. Cells. 2024 Sep 16;13(18):1556. doi: 10.3390/cells13181556. Cells. 2024. PMID: 39329740 Free PMC article. Review. - Constitutive activity of NF-kappa B in myeloid cells drives pathogenicity of monocytes and macrophages during autoimmune neuroinflammation.
Ellrichmann G, Thöne J, Lee DH, Rupec RA, Gold R, Linker RA. Ellrichmann G, et al. J Neuroinflammation. 2012 Jan 20;9:15. doi: 10.1186/1742-2094-9-15. J Neuroinflammation. 2012. PMID: 22260436 Free PMC article. - Immunotherapy of inflammatory demyelinating diseases of the central nervous system.
Bright JJ, Sriram S. Bright JJ, et al. Immunol Res. 2001;23(2-3):245-52. doi: 10.1385/IR:23:2-3:245. Immunol Res. 2001. PMID: 11444389 Review. - Proteinase-activated receptor 2 modulates neuroinflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.
Noorbakhsh F, Tsutsui S, Vergnolle N, Boven LA, Shariat N, Vodjgani M, Warren KG, Andrade-Gordon P, Hollenberg MD, Power C. Noorbakhsh F, et al. J Exp Med. 2006 Feb 20;203(2):425-35. doi: 10.1084/jem.20052148. Epub 2006 Feb 13. J Exp Med. 2006. PMID: 16476770 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources